Sturm, Ruger Feeling the Effects of Desperate Rivals
While demand has picked up, heavy promotional activity in the industry remains a headwind.
Repligen Signals Gene Therapy Strength With 2019 Earnings Report
Guidance for 2020 appears to have spooked investors, but the bioprocess leader is on a solid long-term trajectory.
McDonald's Serving Up Fast-Food-Scented Candles
The world's biggest restaurant chain's newest product lets consumers enjoy the smell of a Quarter Pounder without the calories.
The co-founder and CEO boasts an 18.5% stake in the electric-car maker.
The genetic testing company reported full-year 2019 operating results.
Here's why investors might be disappointed with Aaron's mixed fourth-quarter results.
MediPharm will supply Medical Cannabis by Shoppers with oils, gel caps, and topicals.
From the highs of 2010, Groupon has come down a long way. It needs to change consumer perception to stay relevant today.
The stock is falling due to worries that the aligner company could lose customers in California.
A correction took place today but didn't last long.
The alcoholic beverage giant predicted more competition and higher costs in 2020.
Find out whether retail apocalypse is truly what’s going on today and what the facts are saying.
Revenue grew, earnings fell -- and that's okay.
The freshly reformed media giant published weak fourth-quarter results.
The company has agreed to an acquisition.
The casual fashion retailer plugs into growing secondhand apparel craze by serving as a collection hub for the clothing reseller.
Between new customer UPS and a new USPS contract, the online postage seller is growing again.
Intelsat beat earnings -- and is working to get more money out of the FCC.
The meal kit maker posted another quarter of growing customer defections.
The pizza delivery king is firing on all cylinders.
In theory at least, Harley could buy back 12% of its shares in under 12 months.
Should investors worry as Japan heads towards an inevitable recession?
The specialized health services provider's fourth-quarter financials were uninspiring.